13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 8 managers

Reported value

$43.9M

Holders

8

+1 new · −1 exited

Holders’ est. mark

−$34.2M

Price effect on 6 books still in the name

Largest holder

$20.7M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC836.6K$20.7M−$36MCut−$71.6M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main13.9M$17.2M$2.69MAdded$1.22M
DANSKE BANK A/S72.3K$5.08M−$870.1KCut−$977.1K
Leonteq Securities AG8.79K$617.8K−$40.4KAdded$341.6K
Burton Enright Welch3.69K$259K−$44.4KCut−$47.6K
Prestige Wealth Management Group LLC59$4.15K−$410Added$1.35K

Who left

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.